University of Colorado Cancer Center members Moumita Ghosh, PhD, and Eric Clambey, PhD, have received a grant from the American Lung Association (ALA) to study how epithelial progenitor cells and immune cells may impact each other to shape the outcome of lung cancer. 

---

When a person has lived with colorectal cancer for a long time, and gotten to the point of not responding to therapies as much or at all, it’s common to develop cachexia. This debilitating condition is a multi-systemic wasting syndrome that can cause weight loss, a loss of muscle and bone mass, fatigue, and frailty.

---

Researchers from the University of Colorado Cancer Center on the University of Colorado Anschutz Medical Campus have created a new way of measuring cancer lesions response to treatment that could better inform the development of new cancer drugs.

---

Prostate cancer is the most common cancer in men and, when caught and treated early, is considered curable. But when prostate cancer becomes metastatic, meaning it spreads to distant organs, it is no longer considered curable and novel treatment strategies are needed.

---

Prostate cancer is the second most common and deadly cancer in the United States. The American Cancer Society estimates that 1 in 8 men will receive a prostate cancer diagnosis in their lifetime. Treatment techniques range from aggressive therapies such as radical prostatectomy or radiation therapy to targeted therapies that treat only the affected cancer cells.

---

Every person who receives a cancer diagnosis experiences the symptoms of the disease and treatments differently. However, a common thread is that the disease can influence every aspect of life, even after a person reaches no evidence of disease (NED) status.

---

People often tell Winona Williams that she’s brave, and she is. Ovarian cancer could easily become a dark cloud over her, shadowing every minute of every day.

---

Thanks in part to clinical trials overseen by researchers at the University of Colorado Cancer Center, a wearable, portable electrical device called Optune is proving successful at treating a type of brain tumor called a glioblastoma.

---

September is Blood Cancer Awareness Month, a time for bringing attention to leukemia, lymphoma, myeloma, Hodgkin’s disease, and other blood cancers.

---

As part of its ongoing efforts to eradicate childhood cancers, the St. Baldrick’s Foundation has awarded University of Colorado Cancer Center member Kelly Faulk, MD, a St. Baldrick’s Scholar grant to investigate a new method for treating infant leukemia. 

---

A new phase 2 clinical trial led by University of Colorado Cancer Center member Robert Lentz, MD, may offer hope for patients with metastatic colon cancer for whom standard therapy is no longer effective. Lentz is mentored by Wells Messersmith, MD, associate director of clinical services at the CU Cancer Center.

---

As genetic counseling and genetic testing continue gaining importance in the world of cancer, the new co-director of hereditary cancers in the University of Colorado Cancer Center is aiming to increase awareness of these important resources for patients.

---

The prostate-specific antigen (PSA) is a protein produced by the prostate gland. The PSA test is a blood test used to measure the amount of this protein found in the blood. Results are reported (ng/mL), which means nanograms of PSA per milliliter of blood. High levels of PSA have been found in men with advanced prostate cancer. 

---

Initially, the big picture looks severe: Pediatric brain tumors are now the number one cause of death for children diagnosed with cancer.

Though leukemia is four times more common in pediatric patients than brain tumors, about 90% of children diagnosed with leukemia will experience a cure “because we’ve done such a good job of researching leukemia, and treatments have come so far that cure rates have improved significantly,” says Rajeev Vibhakar, MD, PhD, MPH, a professor of pediatric hematology and oncology in the University of Colorado School of Medicine. “We need to see that same level of support and advancement in finding cures for pediatric brain tumors.”

---

In research that reinforces the University of Colorado Cancer Center’s longstanding relationship with the Leukemia & Lymphoma Society (LLS), CU Cancer Center member Lauren Nicholas, PhD, MPP, is co-principal investigator on a new LLS-funded study to examine the role of Medicare plan selection in dealing with a blood cancer diagnosis.  

---

Each year, about 27,000 women age 45 or younger are diagnosed with breast cancer in the United States. Of those, about 4% are pregnant at the time of their diagnosis.

---

Researchers at the University of Colorado Anschutz Medical Campus have discovered how to extract critical information about breast cancer tumors and disease progression by analyzing blood plasma rather than using more invasive tissue biopsies.

“This is simply a blood draw,” said the study’s senior co-author Peter Kabos, MD, associate professor of medicine in the medical oncology division at the University of Colorado School of Medicine and CU Cancer Center member. “This allows us to look under the surface to see the defining characteristics of the disease. The advantage is that we don’t need to do repeated tissue biopsies.”

---

Deaths from COVID-19 and drug overdoses grabbed a lot of the headlines in 2021, but recently released numbers from the Colorado Department of Public Health and Environment show that cancer was still a leading cause of death in the state, and the number-one cause of death for the 45–84 age range.  

---

For Isaiah Richardson, conducting research as an American Cancer Society Diversity in Cancer Research Intern this summer was an important academic and professional experience, but it was also personal.

---

Less than a year ago, Ken Herfert got a puppy and named her Bailey after the Colorado town where she was born.

This was a big deal for several reasons, including the responsibility of adopting a new family member, but perhaps the biggest was this: About six months after receiving a diagnosis of esophageal cancer in early 2018, Herfert’s oncologist in California told him he had maybe a year to live, maybe less.

---

This episode of CU Anschutz 360 focuses on a promising breakthrough therapy for patients with large B-cell lymphoma, an aggressive subtype of the disease. The clinical trial was led by Manali Kamdar, MD, clinical director of the lymphoma program in the Division of Hematology at the University of Colorado School of Medicine.

---

Family, friends and positive attitudes helped Katherine Haug through months of failed attempts at ridding her body of cancer. Then a passionate doctor with an experimental treatment gave the wife, mother and grandmother a big reason to smile.

---

The effects of cancer are not just physical, especially in advanced stages of the disease. People living with a cancer diagnosis may experience depression, anxiety, and fear, or feel demoralized by the weight of new and unanticipated burdens.

---

For many researchers, the end of a post-doctoral fellowship and entry into a junior faculty position can be a time without a map.

---

Among the biggest obstacles in studying and treating brain tumors are the blood-brain and blood-tumor barriers (BBTB). Generally, just a small amount of drug that is injected into the blood to treat brain tumors is able to penetrate blood vessel walls and accumulate in the brain.

---

After a 30-year, off-and-on battle with metastatic breast cancer, Australian-born actress and singer Olivia Newton-John died on August 8 at age 73. Best known for her role as Sandy in the 1978 movie musical “Grease,” Newton-John also hit the music charts with singles like “Physical” and “Magic.” 

---

A cancer diagnosis can be difficult to work through in the best of circumstances, but factor in barriers related to language, insurance status, educational achievement, geographic location, income level, and more, and the cancer journey — everything from prevention and screening to diagnosis and treatment — can become nearly impossible to traverse. 

---

When the 21^st Century Cures Act went into effect in April 2021, health care organizations began releasing electronic health information (EHI) to patients immediately.

---

All cells in the human body secrete extracellular vesicles (EVs), tiny membrane-enclosed sacs that deliver important cargo – including RNA, proteins, lipids and DNA – to other cells. Cancer cells, notorious for rapid growth, are prolific EV creators.

---

A new study released by the University of Colorado Cancer Center shows that more than 70 percent of breast cancer patients have reported changes that affect their sexual health during and beyond treatment.

---

Denver-area magazine 5280 recently published its list of top doctors for 2022. On this year’s list, CU School of Medicine faculty members continue to be ranked among the best. We're proud to congratulate the 193 CU School of Medicine faculty members honored with the title "Top Doctor."

---

Until 2007, about 1 in 20 lung cancer patients all had the same thing in common but did not know it.

---

For people living with and beyond cancer, one of the most common and limiting side effects is cancer-related fatigue (CRF).

---

A new study from the University of Colorado Cancer Center explores which lung cancer patients are the best candidates for novel therapies that directly target a gene identified as driving certain cancers.

---

Some 100 researchers from around the world were in Aurora last week to discuss the latest findings and news around Kaposi sarcoma herpesvirus (KSHV), the virus that causes a type of cancer known as Kaposi sarcoma.  

---

The bad news about endometrial cancer — cancer that begins in the lining of the uterus — is that it is one of the few cancers that is increasing in incidence even as most other cancers are on the decline, thanks to advances in treatment and prevention.  

---

Large B-cell lymphoma (LBCL) is one of the most aggressive lymphomas and accounts for about 30% of all lymphoma diagnoses.

---

Oncologists have many tools they use to treat cancer, and one of the most commonly used is radiation therapy. In use since the early 1900s, radiation therapy uses high-energy particles or waves — including x-rays, gamma rays, electron beams, and protons — to destroy or damage cancer cells. The machine that delivers radiation therapy has a head that rotates 360 degrees, and patients lie on a special bench that swivels, allowing the radiation to be delivered from any angle.

---

Ward McNeilly thought he was a goner.  

It was summer 2021, and the sarcoma that had started in the Denver resident’s left thigh seemed to be under control, subdued by radiation and chemotherapy following a surgery in 2018 to remove the initial tumor and another surgery in 2019 to remove cancerous tumors in his groin. McNeilly was doing so well, in fact, that his doctors at UCHealth University of Colorado Hospital authorized a “chemo vacation” to give his body a break from some of the side effects of the treatment.

---

Artificial intelligence (AI) can be used to reduce the number of biopsies of benign thyroid nodules, according to new research from University of Colorado Cancer Center member Nikita Pozdeyev, MD. 

---

An exciting and innovative area of cancer research is immunoprevention, in which studies focus on preventing cancer before its onset by using vaccines, antibodies, and other immune mechanisms.

---

Three University of Colorado Cancer Center scientists have received a combined total of almost $2 million in grant funding from the American Cancer Society (ACS) to support research addressing a broad spectrum of cancer prevention, diagnosis, and treatment.

---

Artificial intelligence and machine learning are among the latest tools being used by cancer researchers to aid in detection and treatment of the disease.

---

University of Colorado Cancer Center researchers from the Anschutz and Boulder campuses are collaborating on a broad range of research that recently received AB Nexus support.

---

PIK3CA is a gene that makes an enzyme called PI3K, which is involved in many important cell functions. When PIK3CA mutates, however, it can make the PI3K enzyme become overactive and cause cancer cells to grow.

---

As they both deal with a stage IV colon cancer diagnosis, Kacie Peters and Erik Stanley are focused on living a normal, happy life with their son.

---

Children’s Hospital Colorado is once again ranked among the top 10 children’s hospitals in the country by U.S. News and World Report. The magazine released its 2022–23 Best Children’s Hospitals rankings this week, and Children’s Colorado is ranked number 7 nationally and number 1 in the Rocky Mountain region and state of Colorado.

---

Country music star Toby Keith has been battling stomach cancer, also known as gastric cancer, for the past six months, he announced Sunday on social media.

---

Jimmy Guerrero’s first diagnosis was a possible stomach ulcer, because it seemed inconceivable that a 26-year-old would have colon cancer.

---

Richard Duke, PhD, is taking the next step in his long career at the University of Colorado School of Medicine, joining the CU Cancer Center this July as deputy associate director of commercialization. In his new role, Duke will serve as a liaison to center-level oversight, strategic planning, and process improvement for CU Cancer Center commercialization efforts, working closely with CU Innovations and the Colorado AMC SPARK/REACH program.  

---

Researchers have discovered that infiltrating gliomas, a common brain and spinal cord tumor, are shaped by their genetic evolution and microenvironment, a finding that could lead to more targeted treatments.

---

Bringing with him more than 20 years of experience in gene therapy and personalized medicine, Hatim Sabaawy, MD, PhD, will step into the role of associate director of translational research at the University of Colorado Cancer Center on July 1.

---

---

In recognition of National Cancer Survivors Day on June 5, we wanted to share how far cancer survivorship has come, our efforts at the University of Colorado Cancer Center to further the research that results in survivorship, and some of our survivor stories from the past year.

---

The median age for receiving a bladder cancer diagnosis is 73, and a significant number of those living with the disease are in their 70s and 80s.

---

Michael Boysen didn’t know that a research award from the Endocrine Society was in his future when he started working in the lab of University of Colorado Cancer Center member Matthew Sikora, PhD, last fall. But earlier this month, Boysen — a first-year medical student in the CU School of Medicine — got word that he is one of the recipients of the Endocrine Society’s Research Experiences for Graduate and Medical Students Award for 2022. In addition to $2,500 in research funding, the award includes participation in a summer research project and seminars on career development. 

---

Colorado is known for adventure – from kayaking to skiing, horseback riding to rock climbing, and everything in between. These sports take full advantage of the beauty and challenge of Colorado’s landscape, and often come to define a group of like-minded and spirited individuals who share a passion for adrenaline, community, and focus.

---

Four research projects conducted by University of Colorado Cancer Center members from the University of Colorado Anschutz Medical Campus and Colorado State University recently each received $50,000 pilot grant funding from the Joint Pilot Program of the CU Cancer Center and CSU Flint Animal Cancer Center.

---

Sanjana Bukkapatnam, a fourth-year medical student at the University of Colorado School of Medicine, scored a victory in April when her paper on her glioblastoma research took first place in the National Poster Competition at the American College of Physicians Conference in Chicago. 

---

Molly the golden retriever was a fan of cookies. Whenever there was a plate of them nearby, she kept her eye on it, waiting for her chance to sneak one or five. She was a fan of water, too, even after she had surgery to remove her left front leg following an osteosarcoma, or bone cancer, diagnosis in April 2017.

---

Heide Ford, PhD, professor of pharmacology, has been named chair of the Department of Pharmacology at the University of Colorado School of Medicine, effective June 15.

---

Among the many lessons collectively learned during the initial months of the worldwide COVID-19 pandemic was this: The experience was uncharted psychological and emotional terrain. It wasn’t uncommon for people across the globe to express uncertainty about how to navigate new stresses and new emotions.

---

She was recognized by her peers in 2021 for her leadership at the University of Colorado Cancer Center’s Animal Imaging Shared Resource. Now Natalie Serkova, MSc, PhD, is bringing her expertise to a new role: deputy associate director of all shared resources at the CU Cancer Center.  

---

Hormone therapy is often used to treat prostate cancer that has spread to other parts of the body, but many patients develop resistance to hormone therapy, causing their disease to become more aggressive and potentially more deadly. 

---

 University of Colorado Cancer Center member Janet Kukreja, MD, assistant professor of urology in the University of Colorado School of Medicine, is taking part in this weekend’s Walk to End Bladder Cancer along with her office staff, fellow physicians, and even some of her patients. For this year’s “virtual” event, hosted by the Bladder Cancer Advocacy Network to kick off Bladder Cancer Awareness Month in May, participants walk in their own cities at their own pace, sharing their progress with others around the country. 

---

Michael Joseph Roark – Mike to his friends – met Mary Jo Dougherty in a ski fitness class taught by Anne Kashiwa at the former International Athletic Club in downtown Denver.

---

Receiving a cancer diagnosis can feel like crossing the border into a new country, one with its own language, customs, and laws. Following a cancer diagnosis, people may find themselves sprinting to absorb a new vocabulary of often intimidating words.

---

There are four broad categories of cancer research. The University of Colorado Cancer Center has researchers working in each of these four areas, collaborating to prevent and conquer cancer.

---

This year, lung cancer will account for an estimated 130,000 deaths in the United States – approximately 25% of all cancer deaths. Among those deaths, people who are Black will be disproportionately represented.

---

 As a former dancer and dance instructor, CU Cancer Center member Jennifer Raybin, PhD, knows the power the creative arts hold to help people through challenging times. As a nurse practitioner who led the Palliative Care Program at Children’s Hospital Colorado, she knows the creative arts can be especially helpful for children and young adults with cancer. Creative activities help patients deal with symptoms, improve their mood, and even ease disease and treatment symptoms like pain, nausea, and fatigue.

---

---

---

The development of the anti-cancer immunotherapy drugs called immune checkpoint inhibitors has improved treatment for many cancer patients, but patients with mucosal melanomas — melanomas that occur not on the skin but in the mucous membranes in the head, neck, eyes, respiratory tract, and genitourinary region — are particularly resistant to immune checkpoint inhibitors for reasons researchers don’t fully understand. 

---

To understand why Beau Gill built a mental cupboard for Jeff and Spike, first you must travel back with him to the small town of Catemaco in Mexico’s state of Veracruz.

---

At first blush, the numbers aren’t great: Cancer patients who are covered by Medicaid tend to have later-stage disease and higher rates of mortality.

---

April has been designated National Minority Cancer Awareness Month to bring attention to the health disparities that lead to higher rates of cancer in Black, Hispanic, American Indian/Alaskan Native, and other communities of color. 

---

An enzyme that has been identified as instrumental in the progression of many types of cancer is meeting its match in inhibitors synthesized and evaluated by University of Colorado (CU) Cancer Center researchers.

---

The National Cancer Institute (NCI) has once again recognized the University of Colorado (CU) Cancer Center as one of the best cancer centers in the country. On March 31, the NCI officially renewed the CU Cancer Center’s “comprehensive” designation with a strong rating, the best ever received at the CU Cancer Center. The award recognizes the center’s strengths in basic, translational, clinical, and population science research, as well as leadership and resources devoted to community outreach and engagement and cancer research, training, and education.

---

For so many years, Kelly Noonan prioritized a lot of elements in her life – her family, her career as a nurse, her friends, her responsibilities as a community volunteer.

---

While conducting research for her doctoral dissertation, Channing Tate, PhD, MPH, spoke with 144 older Black adults about hospice care – what they knew about it, whether they’d consider it, what their experiences with hospice had been.

---

Colorectal cancer, the third most commonly-diagnosed cancer in the United States (excluding skin cancers) and second leading cause of cancer-related mortality, is increasingly affecting people in their 20s and 30s, recently published research shows.

---

University of Colorado (CU) Cancer Center member Tejas Patil, MD, is one of three researchers to receive a combined $1 million grant from the Hamoui Foundation and LUNGevity Foundation to study RET-positive lung cancer. 

---

A University of Colorado (CU) Cancer Center researcher has found, through extensive data analysis, that the youngest patients with brain tumors – those ages birth to 3 months – have about half the five-year survival rate as children ages 1 to 19.

---

When Myles Krick started his freshman year of college in fall 2021, he couldn’t help but look back to 15 years ago, when he received the brain cancer diagnosis that made his family worry he might not live long enough to go to college. 

---

Dianne Primavera wouldn’t take no for an answer.  

---

---

In normal human development, the SIX1 gene is critical for embryonic muscle development. After a person is born and as they mature, SIX1 is downregulated, or becomes less prevalent in cells.

---

March is Kidney Cancer Awareness Month, and to get the latest information on the disease, we spoke with University of Colorado (CU) Cancer Center member Elaine Lam, MD, FACP, an associate professor of medicine in the Division of Medical Oncology at the University of Colorado School of Medicine. 

---

University of Colorado (CU) Cancer Center researchers have been on the leading edge of developing new therapies for leukemia. One of the most recent breakthrough therapies has been the development of venetoclax, a B-cell lymphoma-2 inhibitor, that that has shown profound results for adults with acute myeloid leukemia (AML) and has become a standard of care for patients with this disease all over the world.

---

---

There were a lot of things Jim White thought he’d never do: stay in one place long enough to feel roots grow beneath his feet, meet the love of his life, have a child whose daily joy in discovering the world reignites White’s own joy.

---

Even as exciting developments are happening in cervical cancer research, an estimated 14,100 new cases of invasive cervical cancer will be diagnosed in the United States this year.

---

The University of Colorado Cancer Center is pleased to announce that Marie Wood, MD, has been named the medical director of the Cancer Clinical Trials Office (CCTO).

---

The Tumor-Host Interactions Program (THI) at the University of Colorado Cancer Center has awarded four CU Cancer Center researchers $30,000 each to gain preliminary data using the Multiplex Ion Beam Imager (MIBI) housed in the cancer center’s Human Immune Monitoring Shared Resource (HIMSR) to support a competitive national grant proposal. The selected researchers are expected to submit a national competitive grant proposal within six months of completing their THI-MIBI pilot studies.  

---

Can dietary strategies like intermittent fasting or time-restricted eating help breast cancer survivors prevent their tumors from recurring? It’s a question researchers at the University of Colorado (CU) Cancer Center are looking to answer with a new study funded by a $3 million R01 grant from the National Cancer Institute.

---

On a mission to increase early detection of esophageal cancer, University of Colorado (CU) Cancer Center member Sachin Wani, MD, is leading a study to see if a novel diagnostic platform can help endoscopists better identify the disease in patients with a condition called Barrett’s esophagus.

---

On this World Cancer Day, the University of Colorado (CU) Cancer Center looks back to earlier this week when President Biden reignited his Cancer Moonshot initiative, setting ambitious goals to “reduce the death rate from cancer by at least 50% over the next 25 years and improve the experience of people and their families living with and surviving cancer — and by doing this and more, end cancer as we know it today.” 

---

In recognition of World Cancer Day, we talk with Ross Camidge, MD, PhD, professor and director of thoracic oncology at the University of Colorado School of Medicine and member of the CU Cancer Center.

---

University of Colorado (CU) Cancer Center leader Wells Messersmith, MD, has been named chief medical officer of oncology services at UCHealth. In this new role, Messersmith will oversee cancer care at all UCHealth locations with a focus on expanding advanced treatments and the clinical trials UCHealth offers in partnership with the CU Cancer Center.

---

 Comedian Louie Anderson — known for his stand-up routines, as well as a hosting stint on “Family Feud,” his animated series “Life With Louie,” and a more recent role on the FX comedy series “Baskets” — died January 21of diffuse large B-cell lymphoma. He was 68.

---

When Colorado Governor Jared Polis declared January National Radon Action Month, he noted that about 50 percent of Colorado homes test at or above the guideline level at which the U.S. Environmental Protection Agency (EPA) recommends remediation.

---

The University of Colorado School of Medicine is proud of our faculty's work at UCHealth that contributes to its annual rankings on the U.S. News & World Report's Best Hospitals. These rankings are important as many students, residents, faculty, and patients consider these rankings when deciding where to train, practice and receive care.

---

Two research investigations being led by University of Colorado Cancer Center researchers are receiving grant support this year from Wings of Hope for Pancreatic Research.

---

The American Cancer Society (ACS) released its annual cancer statistics last week, reporting that the risk of dying from cancer in the U.S. has fallen 32% over the past 28 years. Cancer deaths in the U.S. reached their peak in 1991, with 215 out of every 100,000 people dying from cancer, and have been falling ever since, largely due to a decline in the amount of people who smoke.

---

Three research teams at the University of Colorado Cancer Center have received $50,000 grants from the Denver Chapter of Golfers Against Cancer to support their research in fighting the disease.

---

Despite the challenges of the COVID-19 pandemic, the University of Colorado School of Medicine still had many accomplishments to celebrate in 2021.

---

Carlos J. Castro transferred his care to Elizabeth Kessler, MD, University of Colorado Cancer Center member, after learning about a clinical trial that gave him a new treatment option for his stage 4 prostate cancer.

---

Emma Lamping, a second-year student at the University of Colorado School of Medicine, has received a $5,000 “Emerging Scientist Award” from the Institute of Cannabis Research in Pueblo, Colorado, for her work on a research study comparing postoperative pain medication requirements and surgical outcomes after major abdominal surgery for the treatment of cancer between daily cannabis users and nonusers of cannabis.

---

In the past, molecular and cellular oncology research often began with the idea that cells are cells and proteins are proteins, and it didn’t especially matter who provided the sample.

---

“Maybe this getting older thing just sucks and that’s how it is.”

---

This was another exciting year for the University of Colorado Cancer Center, and we were able to share more than 80 stories spotlighting our members and their research. We also shared the cancer journeys of some of our patients.

---

Some battles begin before a shot is even fired, with an army building bridges and grading roads, clearing and smoothing the path to make the invading force stronger and more effective.

---

Of the 18,000 people diagnosed with large B-cell lymphoma each year, only half will be successfully treated with chemotherapy. The 9,000 remaining patients typically have poor outcomes, with only 25% responding to additional, higher-intensity chemotherapy, followed by a stem cell transplant.

---

The University of Colorado Cancer Center is pleased to announce several leadership transitions that will support the center in its mission to overcome cancer through innovation, discovery, prevention, early detection, multidisciplinary care, and education.

---

Thomas Delong, PhD, remembers the first time he saw the walnut-sized tumor growing on the base of his tongue.

---

It’s worth noting, in light of recently published research, that a majority of people won’t be diagnosed with cancer in their lifetimes. According to the National Cancer Institute, about 40% of people will, which means 60% won’t.

---

Sandra Luna-Fineman, MD, treats children and adolescents with cancer from around the U.S. in her role as a pediatric oncologist at Children’s Hospital Colorado, but she knows that children in low- and middle-income countries around the world need her help the most.

---

Dr. Cindy O’Bryant, PharmD, Professor in the Department of Clinical Pharmacy, received a Fulbright Specialist Program Scholar Award. A program of the U.S. Department of State, the Fulbright Specialist Program is a unique opportunity for U.S. academics and established professionals to engage in two to six-week, project-based exchanges at host institutions across the globe. On November 27, Dr. O’Bryant left the U.S. for Nigeria with other oncology pharmacists to share her knowledge and experience in cancer care to advance pharmacy oncology practice. She made time to answer questions before her trip about her award, what she expects from the field, and what she hopes to share with medical professionals in Nigeria.

---

At her lowest point, after hearing there wasn’t much more that medicine or science could do for her, Connie Walters asked her best friend and ex-husband, Abel, to stay with her overnight. She wasn’t sure she would wake up and she didn’t want to die alone.

---

Looking to improve methods to treat patients with sepsis, Richard Tobin, PhD, an assistant research professor of surgical oncology in the University of Colorado School of Medicine, and Laurel Hind, PhD, an assistant professor in the biomedical engineering program at the University of Colorado Boulder, are teaming up to study the role of myeloid-derived suppressor cells (MDSCs) in sepsis.

---

With the quiet comfort of a caring partner, Sue Krummrei reaches over and pats her husband’s leg as he breaks down on camera.

---

Two University of Colorado Cancer Center physicians have been recognized as world experts in in pancreatic neoplasms by the 2021 Expertscape rankings.

---

One of the primary tools that oncologists use to stage cancers is the PET (positron emission tomography) scan, an imaging test that uses a small amount of radioactive sugar to detect metabolically active areas within the body.

---

Scott Oliver, MD, chief of the Retina Service and director of the Eye Cancer Program at the University of Colorado School of Medicine, has been named the inaugural Vitale-Schlessman Endowed Chair in Retinal Diseases at the Sue Anschutz-Rodgers Eye Center, effective Nov. 1, 2021. 

---

Lung cancer screening is recommended only for those who are at high risk for the disease — adults ages 50­–80 who smoke at least 20 packs a year — but even among members of that high-risk group, screening rates remain low, ranging from 5% to 20% of those eligible for the screening CT scan.

---

It was just a cough – a nagging one, sure, but nothing too serious, Duane Cerniglia thought. Give it some time and it will go away.

---

“When you lose hope, you lose everything,” says Ron Randolph. “It’s like you’re in the bottom of a hole and you see this light at the top of the hole. It’s a very small light, but there’s no way to escape.”

---

Janice Woodward was already a member of the club nobody wants to join — the cancer club, membership involuntary — when she got an irregular mammogram result in May 2019.

---

The cancer diagnosis came at a time when it seemed as though everything was happening – he was only 37 and soon to become president of the Denver City Council; his three children were ages 4, 6, and 9; he had just run the BOLDERBoulder 10K.

---

There are two things most people believe about lung cancer, says Jamie Studts, PhD, co-leader of the Cancer Prevention & Control Program at the CU Cancer Center: Those who suffer from it most likely caused it by using tobacco, and the prognosis for surviving the disease is poor.

---

When a woman receives a breast cancer diagnosis, she may have many questions about her immediate future – the stage of the disease, what treatment she’ll receive, where it will happen.

---

Three researchers from the University of Colorado Cancer Center have received grants from the V Foundation, a cancer research nonprofit founded in 1993 by college basketball coach Jimmy Valvano, who died of cancer.

---

In a grim reminder of the toll COVID-19 can take even among those who are vaccinated against it, former Secretary of State Colin Powell died Monday of complications from the virus. His family said Powell, who was 84, was fully vaccinated against the disease.

---

The first time Caley Kurchinski had to think about a double mastectomy, she was only 16. Her mother had died at age 36 from breast cancer, when Caley was 6. When she became a teenager, Caley’s family physician began telling her she needed to get genetic testing.

---

Erica Ramsthaler was only given three years to live when she was first diagnosed with colorectal cancer, but after transferring her care to the University of Colorado Cancer Center, she is thriving more than four years later.

---

Kirsten Stewart was just putting on lotion, like she does every morning after her shower. That particular morning, though, she noticed something different: a lump that hadn’t been there before and that definitely wasn’t normal. She was only 30 years old.

---

Tommy Stewart was already a prostate cancer survivor when, during his annual physical in 2004, his physician felt a nodule on his neck.

---

The cancer survivorship journey can have many components, but one of the most important is regular exercise. Physical activity for individuals who have completed cancer treatment can build stamina, reduce anxiety, improve quality of life and physical fitness, and even improve survival outcomes.

---

One of the reasons why cancer continues developing and growing is not just because cancer cells exist, but because they can recruit help from the body’s own blood vessels, stromal cells, and immune cells.

---

 It’s one of the most heartbreaking things Adam Green, MD, sees as a pediatric oncologist: children who beat their cancer, only to see an incurable brain tumor arise five years later.

---

Actor Willie Garson was probably best known for his role as Stanford Blatch on “Sex and the City,” playing one of Carrie Bradshaw’s New York-savvy best friends.

---

Recent advances in immunotherapy have allowed doctors at the University of Colorado Cancer Center to more effectively treat melanomas that spread to other parts of the body. Immunotherapy drugs such as checkpoint inhibitors, which are commonly used to treat melanomas, work to strengthen a patient’s immune system so that it can prevent a tumor from “turning off” the ability of the immune system to fight it.

---

A crucial challenge in cancer research is figuring out how to make immunotherapies more effective, channeling, and selectively guiding the body’s own immune responses in targeting and killing tumors.

---

Breast cancer patients whose cancer spreads to the brain may soon have new treatment options, thanks to research led by CU Cancer Center member Diana Cittelly, PhD.

---

University of Colorado Cancer Center member M. Eric Kohler, MD, PhD, was awarded a three-year, $270,650 Young Investigator Grant from CureSearch for Children’s Cancer, in partnership with the SebastianStrong Foundation, to develop a new treatment approach for acute myeloid leukemia (AML), a rare blood cancer in children.

---

Comedian and former “Saturday Night Live” cast member Norm MacDonald died Tuesday, after what his brother, Neil MacDonald, described as a nine-year battle with acute leukemia. Norm MacDonald, known for his intelligence and sarcastic wit, was 61.

---

Looking to understand why some brain tumors with a specific mutation can start to reject drugs commonly used to treat them, CU Cancer Center member Jean Mulcahy Levy, MD, led researchers from institutions around the country — including several from the University of Colorado School of Medicine — to study samples of brain tumors before and after being treated with the drug.

---

Evan Conant was one of the lucky ones. His stage I colon cancer was caught early, during a routine colonoscopy, and doctors at the University of Colorado Cancer Center were able to perform a surgery to remove the tumors entirely.

---

One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors (short for poly adenosine diphosphate-ribose polymerase). PARP inhibitors are a type of cancer drug that blocks the PARP enzyme from helping to repair DNA damage in cancer cells.

---

When Dara Aisner, MD, PhD, an associate professor in the Department of Pathology at the University of Colorado School of Medicine, was approached by a colleague at another university about splitting the cost of a bulk purchase of new clinical testing products, she initially declined. Although it would be a valuable resource — and might even save her lab money in the long-term — the short-term cost was prohibitive.

---

The diagnosis came as a shock. Although, looking back, Bill Mordecai says it shouldn’t have been. 

---

After suffering from painful bouts of pancreatitis for more than a decade, Christina Gonzalez felt resigned to a seemingly endless cycle of procedures.

---

The doctors she saw initially didn’t seem too concerned, but 22-year-old Ella Neal knew something was seriously wrong. A persistent, unusual abdominal pain was keeping her up at night and distracting her from her studies at the University of Colorado Boulder.

---

David Kooyman transferred his care to University of Colorado Cancer Center member and associate professor of thoracic oncology, Tejas Patil, MD, to be part of a clinical trial to help with his rare lung cancer gene fusion.

---

Richard Schulick, MD, MBA, director of the University of Colorado Cancer Center, becomes close with all of his patients, but he has a special bond with Gerry Turner, one of Schulick’s surgical patients for pancreatic cancer.

---

Comedian Kathy Griffin’s recently announced lung cancer diagnosis came early and arose from a non-related health screening. A lucky catch, and an understandable path to detection for a person who never smoked.

---

Despite the growing threat of the Delta variant, many Americans who have been vaccinated against COVID-19 are living life much as they did pre-pandemic — traveling, shopping, going out to eat, and forgoing masks in many situations.

---

The most important factor predicting the survival of pancreatic cancer patients is whether the cancer can be surgically removed (whether the cancer is “resectable”). The answer isn’t always clear.

---

Each year, Denver-area magazine 5280 publishes its list of top doctors. On this year’s list, which came out last week, CU School of Medicine faculty members continue to be ranked among the best. We are proud to congratulate the 138 CU School of Medicine faculty members honored with the title Top Doctor.

---

Comedian Kathy Griffin, 60, shared the news with the world Monday via Twitter: She was about to undergo surgery for stage I lung cancer.

---

The Colorado Cancer Coalition launched the 2021­–2025 Colorado State Cancer Plan in the town of Cheyenne Wells on July 23, in concert with the Communities That Care Community Action Plan with Cheyenne County Local Public Health. More than 40 Cheyenne County residents joined in person, and nearly 100 more joined virtually. One of the Colorado Cancer Coalition's main priorities is to focus on increasing capacity and screening rates in rural and frontier counties. Over the past year, the coalition has focused on Cheyenne County, which has the second highest age-adjusted incidence rate of cancer in Colorado.

---

Though the two main histological types of breast cancer — lobular and ductal — are treated with the same hormonal therapies, women with lobular breast cancer often have recurrence or metastasis of the disease several years after their initial treatment.

---

When you ask a classroom full of middle schoolers what they want to be when they grow up, you’re likely to get a range of answers, from “pro athletes” and “astronauts” to “musicians” and “movie stars.”

---

The early days of the COVID-19 pandemic were an adjustment period for medical professionals across the board, but they brought up particular challenges for the Cancer Clinical Trial Office (CCTO) at the University of Colorado Cancer Center. A number of procedures that used to take place in person or in the office — collecting signatures from patients and doctors, delivering medications, submitting data to trial sponsors — suddenly had to be done in a whole new way.

---

A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC).

---

It’s difficult enough when a loved one is diagnosed with cancer, but employed spouses of those who receive the diagnosis also are confronted with an array of practical problems. It’s now up to them to untangle issues around medical leave, health insurance, caregiving benefits, and more.

---

Dmitri Simberg, PhD, an associate professor in the Department of Pharmaceutical Sciences in the Skaggs School of Pharmacy and a CU Cancer Center member, has released the results of a new study of the effectiveness of different types of fluorescent labels used to monitor the accumulation of liposomes in tumors.

---

As director of the Animal Imaging Shared Resource at the University of Colorado Cancer Center, Natalie Serkova, PhD, has played an integral part in many groundbreaking projects on the Anschutz Medical Campus.

---

Since a chance discovery by U.S. Army scientists studying mustard gas during World War II, chemotherapy has added countless years to cancer patients’ lives around the world.

---

U.S. News and World Report released its 2021–22 Best Children’s Hospitals rankings this week. Children’s Hospital Colorado ranked number 6 nationally and placed seven pediatric specialties in the top 10, including a number-one ranking for gastroenterology and gastrointestinal surgery. Children’s Colorado is affiliated with the University of Colorado School of Medicine. Together, the institutions are a national center for clinical care and medical research.

---

Patients’ rights advocates scored a major victory in April, when a provision went into effect that allows patients immediate access to all information in their medical records, including physician notes and test results. The change is part of the 21st Century Cures Act, which was passed by Congress in 2016 and continues to be updated.

---

After seeing the tragic COVID-19 crisis unfolding in India, Saketh Guntupalli, MD, associate professor of gynecologic oncology in the University of Colorado School of Medicine and member of the University of Colorado Cancer Center, decided to do something about it.

---

Medical cannabis was legalized in Colorado in 2000, but 20 years later, Camille Stewart, MD, isn’t able to prescribe it to her patients. Nor is she able to dictate the dosage or frequency with which patients take the drug.

---

Melissa Turner had already survived two bouts of breast cancer, so the last thing she expected to hear in early 2018 after experiencing a series of mysterious symptoms was, “You’ve got lung cancer.”

---

If you live in or have visited Colorado, you most likely noticed that the state loves its outdoors. With 300 days of sunshine a year, many enjoy hiking, playing at a park or grabbing a craft brew on a patio. But with that love of sunshine comes an increased risk for skin cancer.

---

In a 1983 concert video, guitar legend Eddie Van Halen abandons his pick as he sets the stage for his famous "Eruption" solo. After popping the pick into his mouth and tucking a cigarette into the top strings of his guitar, the well-loved musician’s fingers fly across his instrument’s neck, a trail of smoke rising from it with every wailing note.

---

Although prostate cancer is treatable when found early, there are common fears that men share concerning prostate cancer.

“I hear from patients all the time stating they do not want to get tested and they do not want to know if they have prostate cancer. Due to the possible side effects associated with treatment,” says Paul Maroni, MD, associate professor in the Department of Surgery, Urology Division, program director of the Urologic Cancer Care Center and University of Colorado (CU) Cancer Center member.

---

Growing up, Douglas “Bucky” Dilts was all too familiar with the dangers of cancer. “My mother ran a cancer tumor registry at St Joseph's Hospital in Atlanta, Georgia for over 25 years. She was always telling us about different types of cancer, so cancer was always at the forefront.”  

---

From “No Hair Don’t Care” to “Keep Calm and Colorado On,” four friends facing two grim diagnoses used humor and grit in their battles against cancer. All four contend that, without their outlook and a little fate, their crusade might have had a different ending.

---

Chadwick Boseman’s all-too-early death has cast the spotlight on a trend University of Colorado School of Medicine doctors have been heralding for nearly two decades. Colorectal cancer, the disease that took the acclaimed actor of “Black Panther” fame, no longer falls in the old-person’s disease bucket.

---

Steve Becker always looks forward to Veterans Day. He and his father, Don, both did hitches in the Navy, so it’s a special day they set aside to hang out and reflect on their service to the nation.

---

Karen Possehl was diagnosed with cancer in November 2016. At the Mayo Clinic in Arizona, her doctor told her that the type of cancer she had was inoperable and wouldn't respond to radiation or chemotherapy. He expected her to live only a few more months.

---

The CU Sarcoma Clinic is pleased to welcome Breelyn A. Wilky, MD, to our multidisciplinary team. Dr. Wilky joined the Medical Oncology faculty in the cancer clinic on November 1, 2018.

---